Impact of fluvoxamine on outpatient treatment of COVID-19 in Honduras in a prospective observational real-world study

• Main Authors: Estela Pineda (Author), Jarmanjeet Singh (Author), Miguel Vargas Pineda (Author), Jose Garay Umanzor (Author), Fernando Baires (Author), Luis G. Benitez (Author), Cesar Burgos (Author), Anupamjeet Kaur Sekhon (Author), Nicole Crisp (Author), Anita S. Lewis (Author), Jana Radwanski (Author), Marco Bermudez (Author), Karen Sanchez Barjun (Author), Oscar Diaz (Author), Elsa Palou (Author), Rossany E. Escalante (Author), Carlos Isai Hernandez (Author), Mark L. Stevens (Author), Deke Eberhard (Author), Manuel Sierra (Author), Tito Alvarado (Author), Omar Videa (Author), Miguel Sierra-Hoffman (Author), Fernando Valerio-Pascua (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: The COVID-19 pandemic has impacted millions of lives globally. While COVID-19 did not discriminate against developed or developing nations, it has been a significant challenge for third world countries like Honduras to have widespread availability of advanced therapies. The concept of ea...